Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer

Breast Cancer

Volumn 18, Issue 2, 2011, Pages 120-123

  Tokunaga, Eriko ^a   Okada, Satoko ^a   Kitao, Hiroyuki ^a   Shiotani, Satoko ^a   Saeki, Hiroshi ^a   Endo, Kazuya ^a   Morita, Masaru ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

FANCF; Methylation; Methylation specific PCR; Triple negative breast cancer

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FANCONI ANEMIA GROUP F PROTEIN; GENOMIC DNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESISTANCE; CONTROLLED STUDY; DNA METHYLATION; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; JAPANESE; POLYMERASE CHAIN REACTION; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; DNA METHYLATION; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; FEMALE; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN;

EID: 79956372634     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-009-0175-z     Document Type: Article

References (26)

1. S Cleator W Heller RC Coombes 2007 Triple-negative breast cancer: therapeutic options Lancet Oncol 8 235 244 17329194 10.1016/S1470-2045(07)70074- 8 (Pubitemid 46291713)
2. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen, et al. 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528:DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
3. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
4. N Turner A Tutt A Ashworth 2004 Hallmarks of 'BRCAness' in sporadic cancers Nat Rev Cancer 4 814 819 15510162 10.1038/nrc1457 1:CAS:528: DC%2BD2cXos1ymu7g%3D (Pubitemid 39331153)
5. NC Turner JS Reis-Filho 2006 Basal-like breast cancer and the BRCA1 phenotype Oncogene 25 5846 5853 16998499 10.1038/sj.onc.1209876 1:CAS:528:DC%2BD28XhtVSgurjO (Pubitemid 44453440)
6. H Farmer N McCabe CJ Lord AN Tutt DA Johnson TB Richardson, et al. 2005 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 917 921 15829967 10.1038/nature03445 1:CAS:528:DC%2BD2MXjtFOmsrc%3D (Pubitemid 40559006)
7. EA Rakha JS Reis-Filho IO Ellis 2008 Basal-like breast cancer: a critical review J Clin Oncol 26 2568 2581 18487574 10.1200/JCO.2007.13.1748
8. A Lyakhovich J Surralles 2006 Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer Cancer Lett 232 99 106 16246487 10.1016/j.canlet. 2005.07.038 1:CAS:528:DC%2BD28XjsF2juw%3D%3D (Pubitemid 43053937)
9. W Wang 2007 Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins Nat Rev Genet 8 735 748 17768402 10.1038/nrg2159 1:CAS:528:DC%2BD2sXhtVCrsb3J (Pubitemid 47429206)
10. H Joenje KJ Patel 2001 The emerging genetic and molecular basis of Fanconi anaemia Nat Rev Genet 2 446 457 11389461 10.1038/35076590 1:CAS:528:DC%2BD3MXktlKqu78%3D (Pubitemid 33673411)
11. JP de Winter L van der Weel J de Groot S Stone Q Waisfisz F Arwert, et al. 2000 The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG Hum Mol Genet 9 2665 2674 11063725 10.1093/hmg/9.18.2665
12. Z Wang M Li S Lu Y Zhang H Wang 2006 Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway Cancer Biol Ther 5 256 260 16418574 10.4161/cbt.5.3.2380 1:CAS:528:DC%2BD28XntlWkuro%3D
13. T Taniguchi M Tischkowitz N Ameziane SV Hodgson CG Mathew H Joenje, et al. 2003 Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 568 574 12692539 10.1038/nm852 1:CAS:528: DC%2BD3sXjtlamtLo%3D (Pubitemid 36597103)
14. CJ Marsit M Liu HH Nelson M Posner M Suzuki KT Kelsey 2004 Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival Oncogene 23 1000 1004 14647419 10.1038/sj.onc.1207256 1:CAS:528:DC%2BD2cXntlelsQ%3D%3D (Pubitemid 38250946)
15. S Meyer DJ White AM Will T Eden A Sim R Brown, et al. 2006 No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia Br J Haematol 134 61 63 16803569 10.1111/j.1365-2141.2006.06107.x 1:CAS:528:DC%2BD28XntFalsbo%3D (Pubitemid 43830029)
16. G Narayan H Arias-Pulido SV Nandula K Basso DD Sugirtharaj H Vargas, et al. 2004 Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer Cancer Res 64 2994 2997 15126331 10.1158/0008-5472. CAN-04-0245 1:CAS:528:DC%2BD2cXjs1ehsLc%3D (Pubitemid 38581394)
17. K Neveling R Kalb AR Florl S Herterich R Friedl H Hoehn, et al. 2007 Disruption of the FA/BRCA pathway in bladder cancer Cytogenet Genome Res 118 166 176 18000367 10.1159/000108297 1:CAS:528:DC%2BD2sXht12ktLbP (Pubitemid 350125253)
18. M Wei J Xu J Dignam R Nanda L Sveen J Fackenthal, et al. 2008 Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers Breast Cancer Res Treat 111 113 20 17932744 10.1007/s10549-007-9766-6 1:CAS:528:DC%2BD1cXos1Wnsbk%3D (Pubitemid 352009235)
19. SL Lim P Smith N Syed C Coens H Wong M van der Burg, et al. 2008 Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer Br J Cancer 98 1452 1456 18414472 10.1038/sj.bjc.6604325 1:CAS:528:DC%2BD1cXks12gu7g%3D (Pubitemid 351543586)
20. OI Olopade M Wei 2003 FANCF methylation contributes to chemoselectivity in ovarian cancer Cancer Cell 3 417 420 12781358 10.1016/S1535-6108(03)00111-9 1:CAS:528:DC%2BD3sXktlyiurs%3D (Pubitemid 38340287)
21. K Kimura S Toyooka K Tsukuda H Yamamoto H Suehisa J Soh, et al. 2008 The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas Oncol Rep 20 1265 1268 18949431 1:CAS:528:DC%2BD1cXhsVaqtr3J
22. F Hunter J Xie C Trimble M Bur KC Li 2006 Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model Mol Cancer 5 5 16457726 10.1186/1476-4598-5-5
23. Sun J, Chen Z, Zhu T, Yu J, Ma K, Zhang H, et al. Hypermethylated SFRP1, but none of other nine genes "informative" for western countries, is valuable for bladder cancer detection in mainland China. J Cancer Res Clin Oncol. 2009 (in press).
24. E Tokunaga Y Kimura E Oki N Ueda M Futatsugi K Mashino, et al. 2006 Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients Int J Cancer 118 284 289 16049961 10.1002/ijc.21358 1:CAS:528:DC%2BD2MXhtlWqs7fP (Pubitemid 41779066)
25. E Tokunaga E Oki K Nishida T Koga R Yoshida K Ikeda, et al. 2006 Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer Breast Cancer Res Treat 97 199 203 16502017 10.1007/s10549-005- 9112-9 1:CAS:528:DC%2BD28XktFSrt7Y%3D
26. VS Dhillon M Shahid SA Husain 2004 CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin Mol Cancer 3 33 15574200 10.1186/1476-4598-3-33 (Pubitemid 40230539)